WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsNational Research Corp (NRC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 2001% more annual revenue ($2.89B vs $137.39M). NRC leads profitability with a 8.4% profit margin vs -7.3%. NRC earns a higher WallStSmart Score of 42/100 (D).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

NRC

Hold

42

out of 100

Grade: D

Growth: 2.0Profit: 8.5Value: 5.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MMED.

NRCSignificantly Overvalued (-304.4%)

Margin of Safety

-304.4%

Fair Value

$3.40

Current Price

$17.18

$13.78 premium

UndervaluedFair: $3.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

NRC2 strengths · Avg: 10.0/10
Return on EquityProfitability
51.2%10/10

Every $100 of equity generates 51 in profit

Operating MarginProfitability
32.2%10/10

Strong operational efficiency at 32.2%

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

NRC4 concerns · Avg: 2.8/10
P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Market CapQuality
$398.29M3/10

Smaller company, higher risk/reward

Price/BookValuation
27.7x2/10

Trading at 27.7x book value

Revenue GrowthGrowth
-4.6%2/10

Revenue declined 4.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : NRC

The strongest argument for NRC centers on Return on Equity, Operating Margin.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : NRC

The primary concerns for NRC are P/E Ratio, Market Cap, Price/Book.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while NRC is a value play — different risk/reward profiles.

MMED is growing revenue faster at 13.1% — sustainability is the question.

NRC generates stronger free cash flow (6M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NRC scores higher overall (42/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

National Research Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.

Want to dig deeper into these stocks?